- In September 2023, Sanofi collaborated with 35 pharmacies in Berlin, aiming to strengthen its market presence across European countries. This initiative marks a strategic move to expand its business footprint within the region
- In August 2023, Insulet Corporation introduced the Omnipod 5, an automated insulin delivery system, in Germany for Type 1 diabetes patients aged 2 years and older. This launch reinforces the company's commitment to making advanced diabetes care more accessible in Europe
- In July 2023, Tandem Diabetes Care, Inc. received approval from the U.S. FDA for its Tandem Mobi insulin pump, intended for patients aged 6 years and above. This milestone supports the company’s efforts to broaden its product portfolio and enhance pediatric diabetes care
- In March 2023, Diabeloop SA, a prominent provider of automated insulin systems, entered a collaboration with Novo Nordisk A/S to enhance its product offerings and expand its market reach. This partnership is expected to boost innovation and strengthen brand positioning
- In November 2022, Medtronic launched the Medtronic Extended infusion set in the U.S., the world’s first insulin pump infusion set designed for up to 7 days of use. This development signifies a major advancement in insulin pump technology, improving convenience for users
